HMOX1 and melanoma: In a previous study, using primary BRAFV600 mutated melanoma cell lines isolated in house from patients, we observed that both silencing and pharmacological inhibition of HO-1 in combination with PLX4032 further reduced cell viability compared to the effect of PLX4032 alone [17].